CDKN1C Mutations in HELLP/Preeclamptic Mothers of Beckwith-Wiedemann Syndrome (BWS) Patients

Placenta

Volumn 30, Issue 6, 2009, Pages 551-554

  Romanelli, V ^a,b   Belinchon A ^a,b   Campos Barros, A ^a,b   Heath, K E ^a,b   Garcia Minaur S ^a,b   Martinez Glez V ^a,b   Palomo, R ^a,b   Mercado, G ^c   Gracia, R ^a,d   Lapunzina, P ^a,b,d  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

^c Centro Nacional de Genetica Medica de Buenos Aires   (Argentina)

^d RESSC   (Spain)

Author keywords

Beckwith Wiedemann syndrome; CDKN1C; HELLP; Mutations; Overgrowth syndrome; p57KIP2; Placenta; Preeclampsia

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1C;

ARTICLE; BECKWITH WIEDEMANN SYNDROME; DNA SEQUENCE; FLUORESCENCE IN SITU HYBRIDIZATION; HELLP SYNDROME; HUMAN; MUTATIONAL ANALYSIS; PATHOPHYSIOLOGY; PHENOTYPE; POLYMERASE CHAIN REACTION; PREECLAMPSIA; PRIORITY JOURNAL;

BASE SEQUENCE; BECKWITH-WIEDEMANN SYNDROME; CYCLIN-DEPENDENT KINASE INHIBITOR P57; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HELLP SYNDROME; HUMANS; INFANT, NEWBORN; MUTATION; PRE-ECLAMPSIA; PREGNANCY;

EID: 67349262027     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.placenta.2009.03.013     Document Type: Article

References (34)

1. Dokras A., Hoffmann D.S., Eastvold J.S., Kienzle M.F., Gruman L.M., Kirby P.A., et al. Severe feto-placental abnormalities precede the onset of hypertension and proteinuria in a mouse model of preeclampsia. Biol Reprod 75 (2006) 899-907
2. Lapunzina P. Risk of tumorigenesis in overgrowth syndromes: a comprehensive review. Am J Med Genet C Semin Med Genet 137C (2005) 53-71
3. KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes Dev 9 (1995) 639-649
4. Weksberg R., Shuman C., and Smith A.C. Beckwith-Wiedemann syndrome. Am J Med Genet C Semin Med Genet 137C (2005) 12-23
5. Kip2 expression induces preeclampsia-like symptoms in mice. Mol Hum Reprod 12 (2002) 1129-1135
6. Kip2 model of pre-eclampsia. Mol Hum Reprod 13 (2007) 251-263
7. Moses E.K., Lade J.A., Guo G., Wilton A.N., Grehan M., Freed K., et al. A genome scan in families from Australia and New Zealand confirms the presence of a maternal susceptibility locus for pre-eclampsia, on chromosome 2. Am J Hum Genet 67 (2000) 1581-1585
8. Rigourd V., Chauvet C., Chelbi S.T., Rebourcet R., Mondon F., Letourneur F., et al. STOX1 overexpression in choriocarcinoma cells mimics transcriptional alterations observed in preeclamptic placentas. PLoS ONE 3 (2008) e3905
9. Kivinen K., Peterson H., Hiltunen L., Laivuori H., Heino S., Tiala I., et al. Evaluation of STOX1 as a preeclampsia candidate gene in a population-wide sample. Eur J Hum Genet 15 (2007) 494-497
10. Berends A.L., Bertoli-Avella A.M., de Groot C.J., van Duijn C.M., Oostra B.A., and Steegers E.A. STOX1 gene in pre-eclampsia and intrauterine growth restriction. BJOG 114 (2007) 1163-1167
11. Iglesias-Platas I., Monk D., Jebbink J., Buimer M., Boer K., van der Post J., et al. STOX1 is not imprinted and is not likely to be involved in preeclampsia. Nat Genet 39 (2007) 279-280
12. Sohda S., Arinami T., Hamada H., Yamada N., Hamaguchi H., and Kubo T. Methylenetetrahydrofolate reductase polymorphism and pre-eclampsia. J Med Genet 34 (1997) 525-526
13. Zusterzeel P.L.M., Peters W.H.M., Visser W., Hermsen K.J.M., Roelofs H.M.J., and Steegers E.A.P. A polymorphism in the gene for microsomal epoxide hydrolase is associated with pre-eclampsia. J Med Genet 38 (2001) 234-237
14. Laasanen J., Romppanen E.L., Hiltunen M., Helisalmi S., Mannermaa A., Punnonen K., et al. Two exonic single nucleotide polymorphisms in the microsomal epoxide hydrolase gene are jointly associated with preeclampsia. Eur J Hum Genet 10 (2002) 569-573
15. Brenner B., Lanir N., and Thaler I. HELLP syndrome associated with factor V R506Q mutation. Brit J Haemat 92 (1996) 999-1001
16. Kupferminc M.J., Eldor A., Steinman N., Many A., Bar-Am A., Jaffa A., et al. Increased frequency of genetic thrombophilia in women with complications of pregnancy. New Eng J Med 340 (1999) 9-12
17. Faisel F., Romppanen E.L., Hiltunen M., Helisalmi S., Laasanen J., Punnonen K., et al. Susceptibility to pre-eclampsia in Finnish women is associated with R485K polymorphism in the factor V gene, not with Leiden mutation. Eur J Hum Genet 12 (2004) 187-191
18. Kanasaki K., Palmsten K., Sugimoto H., Ahmad S., Hamano Y., Xie L., et al. Deficiency in catechol-O-methyltransferase and 2-methoxyoestradiol is associated with pre-eclampsia. Nature 453 (2008) 1117-1121
19. (Kip2) regulates the proper development of labyrinthine and spongiotrophoblasts. Mol Hum Reprod 6 (2000) 1019-1025
20. KIP2) mutations in familial and sporadic Beckwith-Wiedemann syndrome (BWS) provides a novel genotype-phenotype correlation. J Med Genet. 36 (1999) 518-523
21. Chen C.P. Syndromes and disorders associated with omphalocele (I): Beckwith-Wiedemann syndrome. Taiwan J Obstet Gynecol 46 (2007) 96-102
22. KIP2. Am J Surg Pathol 25 (2001) 1225-1230
23. Murakami Y., Kobayashi T., Omatsu K., Suzuki M., Ohashi R., Matsuura T., et al. Exogenous vascular endothelial growth factor can induce preeclampsia-like symptoms in pregnant mice. Semin Thromb Hemost 31 (2005) 307-313
24. Diaz-Meyer N., Yang Y., Sait S.N., Maher E.R., and Higgins M.J. Alternative mechanisms associated with silencing of CDKN1C in Beckwith-Wiedemann syndrome. J Med Genet 42 (2005) 648-655
25. KIP2) is associated with hypomethylation at KvDMR1 in Beckwith-Wiedemann syndrome. J Med Genet 40 (2003) 797-801
26. Algar E.M., Deeble G.J., and Smith P.J. CDKN1C expression in Beckwith-Wiedemann syndrome patients with allele imbalance. J Med Genet 36 (1999) 524-531
27. Enquobahrie D.A., Meller M., Rice K., Psaty B.M., Siscovick D.S., and Williams M.A. Differential placental gene expression in preeclampsia. Am J Obstet Gynecol 199 (2008) 566 e1-11
28. Irving I. Exomphalos with macroglossia: a study of 11 cases. J Pediatr Surg 2 (1967) 499-507
29. Lage J.M. Placentomegaly with massive hydrops of placental stem villi, diploid DNA content and fetal omphaloceles. Possible association with Beckwith-Wiedemann syndrome. Hum Pathol 22 (1991) 591-597
30. McCowan L.M., and Becroft D.M. Beckwith-Wiedemann syndrome, placental abnormalities, and gestational proteinuric hypertension. Obstet Gynecol 83 (1994) 813-817
31. Aagaard-Tillery K.M., Buchbinder A., Boente M.P., and Ramin K.D. Beckwith-Wiedemann syndrome presenting with an elevated triple screen in the second trimester of pregnancy. Fetal Diagn Ther 22 (2007) 18-22
32. Phillips J.K., Bernstein I.M., Mongeon J.A., and Badger G.J. Seasonal variation in preeclampsia based on timing of conception. Obstet Gynecol 104 (2004) 1015-1020
33. Zhang J., Klebanoff M.A., Levine R.J., Puri M., and Moyer P. The puzzling association between smoking and hypertension during pregnancy. Am J Obstet Gynecol 181 (1999) 1407-1413
34. Palmer S.K., Moore L.G., Young D., Cregger B., Berman J.C., and Zamudio S. Altered blood pressure course during normal pregnancy and increased preeclampsia at high altitude (3100 meters) in Colorado. Am J Obstet Gynecol 180 (1999) 1161-1168